We empower bioscience innovators by offering specialized biomarker testing services for central nervous system (CNS) disorders, including ALS, Huntington’s Disease, Parkinson’s Disease, Alzheimer’s Disease, and Traumatic Brain Injury. Our extensive experience spans preclinical through Phase III studies, enabling us to enhance your research outcomes through expert support in study protocols, trial design, and assay development.
Specific immunoassays performed by nVector include but are not limited to the following:
